Pulmonary Vein Stenting for the Treatment of Acquired Severe Pulmonary Vein Stenosis after Pulmonary Vein Isolation: Clinical Implications after Long-Term Follow-Up of 4 Years

Authors: NEUMANN, THOMAS; KUNISS, MALTE; CONRADI, GUIDO; SPERZEL, JOHANNES; BERKOWITSCH, ALEXANDER; ZALTSBERG, SERGEY; WOJCIK, MACIEJ; ERKAPIC, DAMIR; DILL, THORSTEN; HAMM, CHRISTIAN W.; PITSCHNER, HEINZ-F.

Source: Journal of Cardiovascular Electrophysiology, Volume 20, Number 3, March 2009 , pp. 251-257(7)

Publisher: Wiley-Blackwell

Buy & download fulltext article:

OR

Price: $48.00 plus tax (Refund Policy)

Abstract:

Pulmonary Vein Stenting. 

Introduction: Severe pulmonary vein stenosis (PVS) after catheter ablation of atrial fibrillation (AF) is a well-recognized complication with a further reported incidence of 1.3%. The preferred therapy for symptomatic PVS is pulmonary vein (PV) angioplasty, but this treatment modality is followed by restenosis in 44–70%. Whether there is additional long-term benefit from PVS stenting is uncertain. The aim of this study was the evaluation of the long-term success after PV stenting of severe stenosis.

Methods and Results: Ten patients (pts) with 13 PVS were prospectively evaluated. PV stenting was performed with Palmaz Genesis stents. Magnetic resonance imaging (MRI), lung perfusion scans, and CT-scans were performed before, directly after, and every 12 months thereafter. Primary endpoint of the study was the occurrence of restenosis after PV stenting. After a median follow-up of 47.7 (IQRs 25/75 47.2–48.5) months, the primary endpoint was achieved in 3 out of 13 PVs (23% of the treated PVs). We observed two in-stent restenosis 2 and 4 years after PV stenting. These pts experienced onset of dyspnea some weeks before. After an additional balloon angioplasty, the in-stent restenosis was resolved. In one asymptomatic patient, we observed an occlusion of the PV stent 13 months poststenting. Normalization of lung perfusion was noted 4 years after PV stenting versus directly poststenting in all pts without in-stent restenosis (n = 7).

Conclusion: PVS stenting with stent sizes ≥10 mm seems to be an adequate therapy modality for treatment of severe acquired PVS. Late in-stent restenosis after PVS stenting can occur. The normalization of the initially disturbed lung perfusion scan is possible and remains stable, even 4 years after PVS stenting.

(J Cardiovasc Electrophysiol, Vol. 20, pp. 251-257, March 2009)

Keywords: ablation; arrhythmia; atrial fibrillation; catheter ablation; pulmonary vein stenosis; pulmonary veins; tachyarrhythmias

Document Type: Research Article

DOI: http://dx.doi.org/10.1111/j.1540-8167.2008.01316.x

Affiliations: From the Department of Cardiology, Kerckhoff Heart Center, Bad Nauheim, Germany

Publication date: March 1, 2009

More about this publication?

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page